Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis :
Stephen Trzeciak, MD, MPH, Study Director, Cooper University Hospital
The purpose of this randomized controlled trial is to determine whether inhaled nitric oxide is an effective treatment for microcirculatory dysfunction and acute organ system failure in the early stage of sepsis therapy.
ClinicalTrials.gov identifier NCT00608322
Stephen Trzeciak, MD 856-342-3342 trzeciak-stephen@cooperhealth.edu